Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Tvardi Therapeutics (TVRD) SEC Filings & 10K Form

Tvardi Therapeutics logo
$26.65 -0.23 (-0.86%)
As of 04:00 PM Eastern
Compare

Recent Tvardi Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
3:15 PM		Slate Path Capital LP (Filed by)
Tvardi Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Form SCHEDULE 13G
08/14/2025
3:10 PM		Tvardi Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2025
7:03 PM		Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Tweardy Samuel David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
7:04 PM		Tvardi Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Tweardy Samuel David (Filed by)
Form SCHEDULE 13G/A
07/14/2025
4:00 PM		Tvardi Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
5:05 AM		Tvardi Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
8:04 AM		DePinho Ronald A (Filed by)
Tvardi Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Form SCHEDULE 13G
05/27/2025
7:09 AM		Tvardi Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
3:20 PM		Tvardi Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K/A
05/02/2025
5:12 PM		Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Wirk Shaheen (Reporting)
Form 4/A
05/02/2025
5:19 PM		HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4/A
05/02/2025
3:21 PM		Tvardi Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Tweardy David John (Filed by)
Form SCHEDULE 13G
04/22/2025
1:26 PM		Solas Tvardi Sidecar LLC (Filed by)
Tvardi Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Form SCHEDULE 13G
04/21/2025
4:15 PM		HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Smith Cynthia (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Wirk Shaheen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Shiff Susan Ph.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:15 PM		Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Wirk Shaheen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:50 PM		O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:19 PM		Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:22 PM		Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:24 PM		Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Wirk Shaheen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:26 PM		HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:28 PM		Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:30 PM		O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
The Coin That Could Define Trump’s Crypto Presidency (Ad)

When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”tc pixel

Discover the coin that could define Trump’s crypto presidency.
04/17/2025
5:05 PM		Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:08 PM		Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:11 PM		Smith Cynthia (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:13 PM		Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
5:16 PM		Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2025
3:16 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
3:30 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:30 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:30 PM		Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Form 425
02/17/2025
11:15 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form EFFECT
02/14/2025
4:13 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 424B3
02/14/2025
5:01 AM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form S-4/A
02/06/2025
6:15 PM		Cara Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Posner Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
5:19 AM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form S-4/A
01/21/2025
7:50 AM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
7:53 AM		Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Form 425
01/17/2025
3:43 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
3:44 PM		Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Form 425
12/30/2024
3:02 PM		Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Form 425
12/30/2024
3:01 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:10 PM		Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
Form SCHEDULE 13D/A
12/18/2024
3:26 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
12/18/2024
6:23 AM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
6:25 AM		Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Form 425
11/22/2024
3:09 PM		Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:51 PM		Cara Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Posner Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:21 PM		Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
Form SC 13D
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:TVRD) was last updated on 8/21/2025 by MarketBeat.com Staff
From Our Partners
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...
Brownstone Research | Sponsoredtc pixel
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsoredtc pixel